Literature DB >> 18570892

The paclitaxel site in tubulin probed by site-directed mutagenesis of Saccharomyces cerevisiae beta-tubulin.

Ruth A Entwistle1, Robert D Winefield, Travis B Foland, Gerald H Lushington, Richard H Himes.   

Abstract

Previously, we created a paclitaxel-sensitive strain of Saccharomyces cerevisiae by mutating five amino acid residues in beta-tubulin in a strain that has a decreased level of the ABC multidrug transporters. We have used site-directed mutagenesis to examine the relative importance of the five residues in determining sensitivity of this strain to paclitaxel. We found that the change at position 19 from K (brain beta-tubulin) to A (yeast beta-tubulin) and at position 227 from H (brain beta-tubulin) to N (yeast beta-tubulin) had no effect on the activity of paclitaxel. On the other hand, the changes V23T, D26G and F270Y, drastically reduced sensitivity of AD1-8-tax to paclitaxel. Molecular modeling and computational studies were used to explain the results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570892      PMCID: PMC2577837          DOI: 10.1016/j.febslet.2008.06.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Refined structure of alpha beta-tubulin at 3.5 A resolution.

Authors:  J Löwe; H Li; K H Downing; E Nogales
Journal:  J Mol Biol       Date:  2001-11-09       Impact factor: 5.469

2.  Mutagenesis of beta-tubulin cysteine residues in Saccharomyces cerevisiae: mutation of cysteine 354 results in cold-stable microtubules.

Authors:  M L Gupta; C J Bode; C A Dougherty; R T Marquez; R H Himes
Journal:  Cell Motil Cytoskeleton       Date:  2001-06

3.  Conformation of microtubule-bound paclitaxel determined by fluorescence spectroscopy and REDOR NMR.

Authors:  Y Li; B Poliks; L Cegelski; M Poliks; Z Gryczynski; G Piszczek; P G Jagtap; D R Studelska; D G Kingston; J Schaefer; S Bane
Journal:  Biochemistry       Date:  2000-01-18       Impact factor: 3.162

Review 4.  Microtubules, microtubule-interfering agents and apoptosis.

Authors:  F Mollinedo; C Gajate
Journal:  Apoptosis       Date:  2003-10       Impact factor: 4.677

5.  Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules.

Authors:  Claudia J Bode; Mohan L Gupta; Emily A Reiff; Kathy A Suprenant; Gunda I Georg; Richard H Himes
Journal:  Biochemistry       Date:  2002-03-26       Impact factor: 3.162

Review 6.  Mechanism of action of antitumor drugs that interact with microtubules and tubulin.

Authors:  M A Jordan
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-01

7.  Use of the tubulin bound paclitaxel conformation for structure-based rational drug design.

Authors:  Raphaël Geney; Liang Sun; Paula Pera; Ralph J Bernacki; Shujun Xia; Susan B Horwitz; Carlos L Simmerling; Iwao Ojima
Journal:  Chem Biol       Date:  2005-03

8.  Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin.

Authors:  Mohan L Gupta; Claudia J Bode; Gunda I Georg; Richard H Himes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

9.  The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs.

Authors:  Thota Ganesh; Rebecca C Guza; Susan Bane; Rudravajhala Ravindra; Natasha Shanker; Ami S Lakdawala; James P Snyder; David G I Kingston
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

10.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

View more
  6 in total

1.  Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling.

Authors:  Ruth A Entwistle; Rania S Rizk; Daniel M Cheng; Gerald H Lushington; Richard H Himes; Mohan L Gupta
Journal:  ChemMedChem       Date:  2012-07-16       Impact factor: 3.466

2.  Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agents.

Authors:  Steven C Smith; Dmytro M Havaleshko; Kihyuck Moon; Alexander S Baras; Jae Lee; Stefan Bekiranov; Daniel J Burke; Dan Theodorescu
Journal:  Neoplasia       Date:  2011-01       Impact factor: 5.715

3.  Differences in paclitaxel and docetaxel interactions with tubulin detected by mutagenesis of yeast tubulin.

Authors:  Robert D Winefield; Ruth A Entwistle; Travis B Foland; Gerald H Lushington; Richard H Himes
Journal:  ChemMedChem       Date:  2008-12       Impact factor: 3.466

4.  Dissecting paclitaxel-microtubule association: quantitative assessment of the 2'-OH group.

Authors:  Shubhada Sharma; Chandraiah Lagisetti; Barbara Poliks; Robert M Coates; David G I Kingston; Susan Bane
Journal:  Biochemistry       Date:  2013-03-19       Impact factor: 3.162

5.  Knocking out multigene redundancies via cycles of sexual assortment and fluorescence selection.

Authors:  Yo Suzuki; Robert P St Onge; Ramamurthy Mani; Oliver D King; Adrian Heilbut; Vyacheslav M Labunskyy; Weidong Chen; Linda Pham; Lan V Zhang; Amy H Y Tong; Corey Nislow; Guri Giaever; Vadim N Gladyshev; Marc Vidal; Peter Schow; Joseph Lehár; Frederick P Roth
Journal:  Nat Methods       Date:  2011-01-09       Impact factor: 28.547

6.  Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis.

Authors:  Lalita Das; Bhabatarak Bhattacharya; Gautam Basu
Journal:  BMC Res Notes       Date:  2012-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.